Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients.

MLA

Karaba, Andrew H., et al. “Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients.” MedRxiv : The Preprint Server for Health Sciences, May 2022. EBSCOhost, https://doi.org/10.1101/2022.05.24.22275467.

APA

Karaba, A. H., Kim, J. D., Chiang, T. P.-Y., Alejo, J. L., Abedon, A. T., Mitchell, J., Chang, A., Eby, Y., Johnston, T. S., Aytenfisu, T., Hussey, C., Jefferis, A., Fortune, N., Abedon, R., Thomas, L., Warren, D. S., Sitaras, I., Pekosz, A., Avery, R. K., … Werbel, W. A. (2022). Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients. MedRxiv : The Preprint Server for Health Sciences. https://doi.org/10.1101/2022.05.24.22275467

Chicago

Karaba, Andrew H, Jake D Kim, Teresa P-Y Chiang, Jennifer L Alejo, Aura T Abedon, Jonathan Mitchell, Amy Chang, et al. 2022. “Omicron BA.1 and BA.2 Neutralizing Activity Following Pre-Exposure Prophylaxis with Tixagevimab plus Cilgavimab in Vaccinated Solid Organ Transplant Recipients.” MedRxiv : The Preprint Server for Health Sciences, May. doi:10.1101/2022.05.24.22275467.